Literature DB >> 22170288

Translational genetic approaches to substance use disorders: bridging the gap between mice and humans.

Abraham A Palmer1, Harriet de Wit.   

Abstract

While substance abuse disorders only occur in humans, mice and other model organisms can make valuable contributions to genetic studies of these disorders. In this review, we consider a few specific examples of how model organisms have been used in conjunction with studies in humans to study the role of genetic factors in substance use disorders. In some examples genes that were first discovered in mice were subsequently studied in humans. In other examples genes or specific polymorphisms in genes were first studied in humans and then modeled in mice. Using anatomically and temporally specific genetic, pharmacological and other environmental manipulations in conjunction with histological analyses, mechanistic insights that would be difficult to obtain in humans have been obtained in mice. We hope these examples illustrate how novel biological insights about the effect of genes on substance use disorders can be obtained when mouse and human genetic studies are successfully integrated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170288      PMCID: PMC3352994          DOI: 10.1007/s00439-011-1123-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  58 in total

1.  Mpdz is a quantitative trait gene for drug withdrawal seizures.

Authors:  Renee L Shirley; Nicole A R Walter; Matthew T Reilly; Christoph Fehr; Kari J Buck
Journal:  Nat Neurosci       Date:  2004-06-20       Impact factor: 24.884

2.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

Review 3.  The catechol-O-methyltransferase gene: its regulation and polymorphisms.

Authors:  Elizabeth M Tunbridge
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

4.  Incorporating age at onset of smoking into genetic models for nicotine dependence: evidence for interaction with multiple genes.

Authors:  Richard A Grucza; Eric O Johnson; Robert F Krueger; Naomi Breslau; Nancy L Saccone; Li-Shiun Chen; Jaime Derringer; Arpana Agrawal; Michael Lynskey; Laura J Bierut
Journal:  Addict Biol       Date:  2010-07       Impact factor: 4.280

5.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

6.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior.

Authors: 
Journal:  Nat Genet       Date:  2010-04-25       Impact factor: 38.330

7.  Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice.

Authors:  Francesco Papaleo; Jacqueline N Crawley; Jian Song; Barbara K Lipska; Jim Pickel; Daniel R Weinberger; Jingshan Chen
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

8.  The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.

Authors:  Thomas Kroslak; K Steven Laforge; Robert J Gianotti; Ann Ho; David A Nielsen; Mary Jeanne Kreek
Journal:  J Neurochem       Date:  2007-10       Impact factor: 5.372

9.  A population-specific HTR2B stop codon predisposes to severe impulsivity.

Authors:  Laura Bevilacqua; Stéphane Doly; Jaakko Kaprio; Qiaoping Yuan; Roope Tikkanen; Tiina Paunio; Zhifeng Zhou; Juho Wedenoja; Luc Maroteaux; Silvina Diaz; Arnaud Belmer; Colin A Hodgkinson; Liliana Dell'osso; Jaana Suvisaari; Emil Coccaro; Richard J Rose; Leena Peltonen; Matti Virkkunen; David Goldman
Journal:  Nature       Date:  2010-12-23       Impact factor: 49.962

Review 10.  Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes.

Authors:  David Goldman; Francesca Ducci
Journal:  ScientificWorldJournal       Date:  2007-11-02
View more
  6 in total

1.  Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.

Authors:  Tae-Hwi Schwantes-An; Juan Zhang; Li-Shiun Chen; Sarah M Hartz; Robert C Culverhouse; Xiangning Chen; Hilary Coon; Josef Frank; Helen M Kamens; Bettina Konte; Leena Kovanen; Antti Latvala; Lisa N Legrand; Brion S Maher; Whitney E Melroy; Elliot C Nelson; Mark W Reid; Jason D Robinson; Pei-Hong Shen; Bao-Zhu Yang; Judy A Andrews; Paul Aveyard; Olga Beltcheva; Sandra A Brown; Dale S Cannon; Sven Cichon; Robin P Corley; Norbert Dahmen; Louisa Degenhardt; Tatiana Foroud; Wolfgang Gaebel; Ina Giegling; Stephen J Glatt; Richard A Grucza; Jill Hardin; Annette M Hartmann; Andrew C Heath; Stefan Herms; Colin A Hodgkinson; Per Hoffmann; Hyman Hops; David Huizinga; Marcus Ising; Eric O Johnson; Elaine Johnstone; Radka P Kaneva; Kenneth S Kendler; Falk Kiefer; Henry R Kranzler; Ken S Krauter; Orna Levran; Susanne Lucae; Michael T Lynskey; Wolfgang Maier; Karl Mann; Nicholas G Martin; Manuel Mattheisen; Grant W Montgomery; Bertram Müller-Myhsok; Michael F Murphy; Michael C Neale; Momchil A Nikolov; Denise Nishita; Markus M Nöthen; John Nurnberger; Timo Partonen; Michele L Pergadia; Maureen Reynolds; Monika Ridinger; Richard J Rose; Noora Rouvinen-Lagerström; Norbert Scherbaum; Christine Schmäl; Michael Soyka; Michael C Stallings; Michael Steffens; Jens Treutlein; Ming Tsuang; Tamara L Wall; Norbert Wodarz; Vadim Yuferov; Peter Zill; Andrew W Bergen; Jingchun Chen; Paul M Cinciripini; Howard J Edenberg; Marissa A Ehringer; Robert E Ferrell; Joel Gelernter; David Goldman; John K Hewitt; Christian J Hopfer; William G Iacono; Jaakko Kaprio; Mary Jeanne Kreek; Ivo M Kremensky; Pamela A F Madden; Matt McGue; Marcus R Munafò; Robert A Philibert; Marcella Rietschel; Alec Roy; Dan Rujescu; Sirkku T Saarikoski; Gary E Swan; Alexandre A Todorov; Michael M Vanyukov; Robert B Weiss; Laura J Bierut; Nancy L Saccone
Journal:  Behav Genet       Date:  2015-09-21       Impact factor: 2.805

2.  The genetics of addiction.

Authors:  Nora D Volkow; Maximilian Muenke
Journal:  Hum Genet       Date:  2012-06       Impact factor: 4.132

3.  Αlpha 2a-Adrenoceptor Gene Expression and Early Life Stress-Mediated Propensity to Alcohol Drinking in Outbred Rats.

Authors:  Erika Comasco; Aniruddha Todkar; Linnea Granholm; Kent W Nilsson; Ingrid Nylander
Journal:  Int J Environ Res Public Health       Date:  2015-06-25       Impact factor: 3.390

4.  Sex-dependent associations between addiction-related behaviors and the microbiome in outbred rats.

Authors:  Veronica L Peterson; Jerry B Richards; Paul J Meyer; Raul Cabrera-Rubio; Jordan A Tripi; Christopher P King; Oksana Polesskaya; Amelie Baud; Apurva S Chitre; Thomaz F S Bastiaanssen; Leah Solberg Woods; Fiona Crispie; Timothy G Dinan; Paul D Cotter; Abraham A Palmer; John F Cryan
Journal:  EBioMedicine       Date:  2020-05-08       Impact factor: 8.143

5.  Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).

Authors:  Amy B Hart; Barbara E Engelhardt; Margaret C Wardle; Greta Sokoloff; Matthew Stephens; Harriet de Wit; Abraham A Palmer
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

6.  Methamphetamine-induced conditioned place preference in LG/J and SM/J mouse strains and an F45/F46 advanced intercross line.

Authors:  Camron D Bryant; Loren A Kole; Michael A Guido; Riyan Cheng; Abraham A Palmer
Journal:  Front Genet       Date:  2012-07-11       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.